New 'trolls' are crushing innovation in biopharma
July 22, 2015 at 10:16 AM EDT
Hedge funds and and a new type of patent troll are using loopholes in patent law for gains, stifling innovation, says author Joseph Gulfo.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.